Form EFFECT FibroBiologics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 19, 2026 |
| Accession Number: | 0001193125-26-420437 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics shares preclinical disc disease data at spine meeting
- Cadillac Mines Intersects 10.96 Grams Per Tonne Gold Over 4.4 Metres Approximately 75 Metres Down-Dip of Previous Drilling and Identifies a Third Shear at Galloway’s Moriss Zone
- How California Homeowners Are Refinancing Luxury Properties Without Tax Returns: Mortgage Specialist Jackie Barikhan Shares $3.5M Success Story
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
